Literature DB >> 16786128

Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells.

Osamu Maeda1, Masashi Kondo, Takayoshi Fujita, Noriyasu Usami, Takayuki Fukui, Kaoru Shimokata, Takafumi Ando, Hidemi Goto, Yoshitaka Sekido.   

Abstract

The Hedgehog (Hh) signaling pathway and the Wnt signaling pathway are known to play important roles in carcinogenesis and the progression of various human malignant tumors. Although a relationship between these two pathways has recently been reported, the mechanism by which beta-catenin, one of the key molecules of the Wnt signaling pathway, influences the Hh pathway has not yet been revealed in detail. To clarify the role of beta-catenin in relation to the Hh signaling pathway, we transfected GLI1 and beta-catenin expression constructs into human malignant cells, including stomach, colon, and lung cancers, and evaluated the luciferase activity of GLI-responsive reporter constructs. While exogenous GLI1 increased the luciferase activity, exogenous beta-catenin also enhanced the activity under overexpression of GLI1. However, co-transfection with T-cell factor (TCF)-4 or lymphocyte enhancer factor (LEF)-1 did not influence the activity, indicating that the enhancement of beta-catenin in relation to the Hh signaling pathway is not TCF/LEF-dependent. Our results suggest that beta-catenin might be involved in the Hh signaling pathway via enhancement of the transcriptional activity of GLI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786128

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

Review 1.  Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy.

Authors:  Li Song; Zhuo-Yu Li; Wei-Ping Liu; Mei-Rong Zhao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 2.  Drugging the cancer stem cell compartment: lessons learned from the hedgehog and Wnt signal transduction pathways.

Authors:  Michael E Dodge; Lawrence Lum
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 3.  Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression.

Authors:  Ysrafil Ysrafil; Indwiani Astuti
Journal:  Bioimpacts       Date:  2021-11-29

Review 5.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Authors:  Barbara Stecca; Ariel Ruiz i Altaba
Journal:  J Mol Cell Biol       Date:  2010-01-17       Impact factor: 6.216

6.  Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA.

Authors:  Felicite K Noubissi; Srikanta Goswami; Nicholas A Sanek; Kazuyuki Kawakami; Toshinari Minamoto; Amy Moser; Yevgenya Grinblat; Vladimir S Spiegelman
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

7.  Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.

Authors:  Ronak Ghanbari-Azarnier; Shingo Sato; Qingxia Wei; Mushriq Al-Jazrawe; Benjamin A Alman
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

8.  Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.

Authors:  Nathaniel B Goldstein; Maranke I Koster; Kenneth L Jones; Bifeng Gao; Laura G Hoaglin; Steven E Robinson; Michael J Wright; Smaranda I Birlea; Abigail Luman; Karoline A Lambert; Yiqun G Shellman; Mayumi Fujita; William A Robinson; Dennis R Roop; David A Norris; Stanca A Birlea
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

9.  Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation.

Authors:  Sylviane Dennler; Jocelyne André; Franck Verrecchia; Alain Mauviel
Journal:  J Biol Chem       Date:  2009-09-21       Impact factor: 5.157

10.  Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas.

Authors:  Frédéric Varnat; Irene Siegl-Cachedenier; Monica Malerba; Pascal Gervaz; Ariel Ruiz i Altaba
Journal:  EMBO Mol Med       Date:  2010-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.